Dancey, Janet <br/><br/>
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Feb 2004 
 - 183-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2003.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Docetaxel<br/>Fatigue<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Pain<br/>Quality of Life<br/>Salvage Therapy<br/>Survival Analysis<br/>Taxoids--therapeutic use